We invite you to an evening event with the aim to discuss the recent developments in Alzheimer’s disease (AD) from the current understanding of AD pathology to the latest insights from the clinical experience of LEQEMBI® (lecanemab) in Finland.

This meeting is intended for healthcare professionals from Denmark, Finland, Norway, and Sweden who are attending the ADPD Congress in Copenhagen, 17–21 March 2026.

Program

18.30–19.00 Drop-in

Meeting Moderator: Kristian Steen Frederiksen
Associate Professor, MD, PhD
Rigshospitalet Copenhagen and University of Copenhagen

19.00–19.40 Amyloid more than plaques
Heikki Tanila, MD, PhD, Professor of Translational Neuroscience, A. I. Virtanen Institute, University of Eastern Finland

19.40–20.20 Clinical experience from LEQEMBI® (lecanemab) treatment of patients with early Alzheimerʼs disease in Finland
Minna Raivio, MD, PhD, Associate Professor of Geriatrics University of Helsinki Finland, Terveystalo Helsinki Finland

20.20–21.00 Discussion and Key takeaways from the congress

Contact and Questions
If you have any questions, feel free to reach out to: nordics@bioarctic.com